Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 42 INDUSTRY 5 FED 3 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Genitourinary 1 Gastrointestinal 1

Conditions

Prostatic Neoplasms 83 Urinary Bladder Neoplasms 31 Carcinoma, Renal Cell 9 Carcinoma, Transitional Cell 8 Kidney Neoplasms 7 Recurrence 5 Prostatic Hyperplasia 5 Neoplasms 5 Disease 5 Testicular Neoplasms 3 Pain, Postoperative 3 Pain 3 Non-Muscle Invasive Bladder Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Anxiety Disorders 3 Sleep Initiation and Maintenance Disorders 2 Penile Neoplasms 2 Pancreatic Neoplasms 2 Motor Activity 2 Melanoma 2 Lymphoma 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Breast Neoplasms 2 Adenocarcinoma 2 Acute Kidney Injury 2 Wilms Tumor 1 Vulvar Neoplasms 1 Vomiting 1 Uterine Cervical Neoplasms 1

Interventions

Cell- and Tissue-Based Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Erectile Dysfunction × Genitourinary × Clear all

NCT01089387 2025-12-04

INSTIN

Institut National de la Santé Et de la Recherche Médicale, France

Phase 1/2 Completed

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡